Rhena Klar

Rhena Klar is currently serving as a Wissenschaftlicher Koordinator at DKFZ Deutsches Krebsforschungszentrum since January 2024 and as a Scientific Coordinator at Universitätsklinikum Freiburg since September 2022, where the focus is on establishing a patient-derived organoid biobank. Prior experience includes a PhD candidacy at University Medical Centre Freiburg from June 2018 to July 2022, concentrating on the mechanisms of invasion and metastasis in pancreatic ductal adenocarcinoma using patient-derived 3D-organoids. Rhena Klar also worked as a Scientific Associate at Novartis Oncology and Novartis Institutes for BioMedical Research in 2016. Academic qualifications include a Master of Science in Molekularmedizin and a Bachelor of Science from The University of Freiburg, completed in 2015 and 2013, respectively.